サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：CRISPRおよびcas遺伝子群の市場規模、市場シェア、アプリケーション分析、地域展望、成長動向、主要企業、競争戦略および予測、2023年～2031年
市場調査レポート
商品コード
1283944

CRISPRおよびcas遺伝子群の市場規模、市場シェア、アプリケーション分析、地域展望、成長動向、主要企業、競争戦略および予測、2023年～2031年

CRISPR And Cas Genes Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2023 To 2031
出版日: | 発行: Acute Market Reports | ページ情報: 英文 120 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
CRISPRおよびcas遺伝子群の市場規模、市場シェア、アプリケーション分析、地域展望、成長動向、主要企業、競争戦略および予測、2023年～2031年
出版日: 2023年05月26日
発行: Acute Market Reports
ページ情報: 英文 120 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

CRISPRおよびcas遺伝子群は、遺伝子工学の分野で最も有望なツールの1つとなり、遺伝子編集や遺伝子操作へのアプローチ方法に革命をもたらしています。CRISPR/Casシステムは、細菌に自然に存在するメカニズムで、侵入してくるウイルスから身を守ることを可能にします。このシステムは、特定の遺伝子をターゲットにして変更することができ、研究および医療における強力なツールとなっています。世界のCRISPRおよびcas遺伝子群市場は、今後数年間で大きく成長し、2023年から2031年の予測期間中にCAGRが18.5%に達すると予想されます。この成長は、農業、医薬品、バイオテクノロジーなど様々な用途で遺伝子編集技術の需要が高まっていることに起因しています。CRISPRおよびcas遺伝子群市場の成長に大きく寄与しているのは、製薬業界とバイオテクノロジー業界です。同技術は、幅広い遺伝性疾患の治療が期待され、創薬や薬剤開発に利用されています。また、農業業界では、作物の収量を向上させ、病気に強い作物を開発するためにこの技術を導入しています。

製薬業界における遺伝子編集技術の需要拡大

製薬業界は、CRISPRおよびcas遺伝子群市場の主要な促進要因です。同技術は、幅広い遺伝性疾患を治療できる可能性があり、創薬や医薬品開発に活用されています。世界の遺伝子編集市場は2025年までに95億米ドルに達すると予想されており、CRISPR/Casシステムは最も広く使われている遺伝子編集技術です。CRISPR Therapeutics AG、Intellia Therapeutics、Editas Medicineなど、複数の企業がCRISPRベースの治療法の開発に多額の投資を行っています。

農業におけるCRISPR/Cas技術の採用

農業分野もCRISPRおよびcas遺伝子群市場の成長を後押ししています。この技術は、作物の収量を向上させ、病気に強い作物を開発するために使用されています。世界の農業バイオテクノロジー市場は、2025年には550億米ドルを超えると予想されており、CRISPR/Casシステムはこの成長を牽引する重要な技術の1つとなっています。Bayer AG、DuPont Pioneer、DowDuPontなどの企業は、CRISPR編集作物の開発に多額の投資を行っています。

遺伝性疾患の有病率の上昇

遺伝性疾患の有病率の上昇は、CRISPRおよびcas遺伝子群のような遺伝子編集技術への需要を促進しています。世界保健機関（WHO）によると、遺伝性疾患は世界中で数百万人に影響を及ぼしており、推定で出生児の20人に1人が遺伝性疾患の影響を受けていると言われています。CRISPR/Casシステムは、鎌状赤血球貧血、嚢胞性線維症、ハンチントン病など、さまざまな遺伝子疾患を治療できる可能性を持っています。遺伝性疾患に対するCRISPRベースの治療法の安全性と有効性を検証するための臨床試験がいくつか進行中であり、CRISPRおよびcas遺伝子群市場の成長をさらに促進する可能性があります。

標的外影響と倫理的懸念

CRISPRおよびcas遺伝子群市場の主な抑制要因の1つは、意図しない有害なゲノムの変化をもたらす可能性のあるオフターゲット効果の可能性です。CRISPR/Casシステムは非常に精密ですが、完璧ではなく、オフターゲット効果のリスクも残っています。このため、この技術を遺伝子編集に用いることの安全性や倫理的な意味合いが懸念されています。さらに、この技術を人間の形質を強化するなどの非医療目的で悪用する可能性も懸念されています。これらの懸念は、規制当局の監視の強化や技術の採用の遅れにつながり、CRISPRおよびcas遺伝子群市場の成長を抑制する可能性があります。

バイオメディカルセグメントが市場売上を支配する

CRISPRおよびcas遺伝子群市場は、バイオメディカル分野とアグリ分野の両方で大きな成長が見込まれています。収益面では、創薬や市場開拓における遺伝子編集技術の需要の高さから、バイオメディカルセグメントが市場を独占すると予想されます。バイオメディカルセグメントは2022年にCRISPRおよびcas遺伝子群市場で最大のシェアを占め、同セグメントは2023年から2031年の予測期間中も市場を独占すると予想されます。一方、農業分野は、耐病性・高収量作物への需要の高まりにより、予測期間中に最も高いCAGRを記録すると予想されます。CRISPR/Casシステムは、収量の増加、干ばつ耐性、病害抵抗性などの望ましい形質を持つ作物の開発に利用されています。Bayer AGやDowDuPontを含むいくつかの企業は、CRISPR編集作物の開発に多額の投資を行っており、農業分野の成長をさらに促進する可能性があります。

バイオテクノロジー企業および製薬企業が市場収益を支配する

CRISPRおよびcas遺伝子群市場は、バイオテクノロジーおよび製薬企業、学術および政府研究機関、契約研究機関（CRO）など、最終用途によっても区分されています。バイオテクノロジーおよび製薬会社は、創薬や医薬品開発における遺伝子編集技術の需要が高いことから、収益面で市場を独占すると予想されます。2022年のCRISPRおよびcas遺伝子群市場では、バイオテクノロジーおよび製薬会社セグメントが最大のシェアを占めています。しかし、バイオテクノロジーおよび製薬企業による前臨床および臨床研究活動のアウトソーシングの増加により、2023年から2031年の予測期間中に最も高いCAGRが予想されるのは、契約研究機関（CRO）セグメントです。CROは、創薬・開発、臨床試験、レギュラトリーサービスなど、幅広いサービスを提供しています。前臨床および臨床研究活動におけるCRISPRおよびcas遺伝子群の使用は増加すると予想され、CRO分野の成長をさらに促進する可能性があります。

北米が世界リーダーとして留まる

北米は、この地域に複数の主要プレイヤーが存在し、バイオテクノロジーや製薬業界における遺伝子編集技術の採用率が高いことから、2022年の市場において最大のシェアを占めています。しかし、アジア太平洋地域では、バイオテクノロジー研究への投資の増加や、同地域における遺伝性疾患の有病率の増加により、最も高いCAGRが見込まれています。また、この地域には新興のバイオテクノロジーおよび製薬企業がいくつか存在し、市場の成長をさらに促進する可能性があります。また、欧州は、ゲノム編集研究に対する政府資金の増加や遺伝子組み換え作物に対する需要の高まりから、同市場の成長に大きく貢献すると予想されます。

市場競争は予測期間中に激化へ

CRISPRおよびcas遺伝子群市場は競争が激しく、複数の主要プレーヤーが市場で活動しています。市場のトップ企業には、Thermo Fisher Scientific, Inc.、Editas Medicine, Inc.、CRISPR Therapeutics AG、Intellia Therapeutics, Inc.、Caribou Biosciences, Inc.などの企業があります。これらのプレイヤーは、市場でのプレゼンスを拡大し、製品ポートフォリオを強化するために、戦略的なコラボレーション、パートナーシップ、M&Aに力を入れています。例えば、2020年、サーモフィッシャーサイエンティフィックは、ライフサイエンス分野の提供製品を拡大するため、分子診断およびサンプル調製技術の大手プロバイダーであるQIAGEN N.V.を買収しました。また、エディタスメディシンは、CRISPR遺伝子編集技術を進化させるため、バイオテクノロジーおよび製薬業界の主要プレーヤーと複数の提携を締結しています。さらに、いくつかの主要プレーヤーは、新しく革新的な遺伝子編集技術を開発するために研究開発活動に投資しています。例えば、CRISPR Therapeutics社は、幅広い遺伝性疾患に対するCRISPRベースの治療法のポートフォリオを開発しており、Intellia Therapeutics社は、CRISPR-Cas9遺伝子編集技術のin vivoデリバリーのための独自プラットフォームを開発しています。さらに、各社は遺伝子編集技術に関する規制当局の承認取得にも注力しています。例えば、2019年には、CRISPR TherapeuticsとVertex Pharmaceuticalsが、CRISPR-Cas9技術を用いて鎌状赤血球症を治療する遺伝子治療についてFDAの承認を取得しました。

目次

第1章 序文

  • レポート内容
    • 報告書の目的
    • 対象読者
    • 主な提供商品
  • 市場セグメンテーション
  • 調査手法
    • フェーズⅠ-二次調査
    • フェーズⅡ-一次調査
    • フェーズⅢ-有識者別レビュー
    • 前提条件
    • 採用したアプローチ

第2章 エグゼクティブサマリー

第3章 CRISPRおよびcas遺伝子群の市場：競合分析

  • 主要ベンダーの市場での位置付け
  • ベンダーが採用する戦略
  • 主要な産業戦略
  • ティア分析：2022 vs 2031

第4章 CRISPRおよびcas遺伝子群の市場：マクロ分析と市場力学

  • イントロダクション
  • 世界のCRISPRおよびcas遺伝子群の市場価値 2021-2031
  • 市場力学
    • 市場促進要因
    • 市場抑制要因
    • 主な課題
    • 主な機会
  • 促進要因と抑制要因の影響分析
  • シーソー分析

第5章 CRISPRおよびcas遺伝子群の製品別市場 2021-2031

  • 市場概要
  • 成長・収益分析：2022 vs 2031
  • 市場セグメンテーション
    • キットと酵素
      • ベクトルベースのCas
      • DNAフリーCa
    • ライブラリー
    • デザインツール
    • 抗体
    • その他

第6章 CRISPRおよびcas遺伝子群のサービス別市場 2021-2031

  • 市場概要
  • 成長・収益分析：2022 vs 2031
  • 市場セグメンテーション
    • 細胞株工学
    • gRNAの設計
    • 微生物の遺伝子編集
    • DNA合成

第7章 CRISPRおよびcas遺伝子群のアプリケーション別市場 2021-2031

  • 市場概要
  • 成長・収益分析：2022 vs 2031
  • 市場セグメンテーション
    • 生物医学
      • ゲノム工学
      • 疾患モデル研究
      • 機能的ゲノミクス
      • エピジェネティクス
      • その他
    • 農業

第8章 CRISPRおよびcas遺伝子群の最終用途別市場 2021-2031

  • 市場概要
  • 成長・収益分析：2022 vs 2031
  • 市場セグメンテーション
    • バイオテクノロジーおよび製薬会社
    • 学術機関および政府調査機関
    • 受託調査機関（CRO）

第9章 北米CRISPRおよびcas遺伝子群市場 2021-2031

  • 市場概要
  • CRISPRおよびcas遺伝子群の製品別市場 2021-2031
  • CRISPRおよびcas遺伝子群のサービス別市場 2021-2031
  • CRISPRおよびcas遺伝子群のアプリケーション別市場 2021-2031
  • CRISPRおよびcas遺伝子群の最終用途別市場 2021-2031
  • CRISPRおよびcas遺伝子群の地域別市場 2021-2031
    • 北米
      • 米国
      • カナダ
      • その他北米地域

第10章 英国および欧州連合CRISPRおよびcas遺伝子群市場 2021-2031

  • 市場概要
  • CRISPRおよびcas遺伝子群の製品別市場 2021-2031
  • CRISPRおよびcas遺伝子群のサービス別市場 2021-2031
  • CRISPRおよびcas遺伝子群のアプリケーション別市場 2021-2031
  • CRISPRおよびcas遺伝子群の最終用途別市場 2021-2031
  • CRISPRおよびcas遺伝子群の地域別市場 2021-2031
    • 英国と欧州連合
      • 英国
      • ドイツ
      • スペイン
      • イタリア
      • フランス
      • その他欧州地域

第11章 アジア太平洋 CRISPRおよびcas遺伝子群市場 2021-2031

  • 市場概要
  • CRISPRおよびcas遺伝子群の製品別市場 2021-2031
  • CRISPRおよびcas遺伝子群のサービス別市場 2021-2031
  • CRISPRおよびcas遺伝子群のアプリケーション別市場 2021-2031
  • CRISPRおよびcas遺伝子群の最終用途別市場 2021-2031
  • CRISPRおよびcas遺伝子群の地域別市場 2021-2031
    • アジア太平洋
      • 中国
      • 日本
      • インド
      • オーストラリア
      • 韓国
      • その他アジア太平洋地域

第12章 ラテンアメリカCRISPRおよびcas遺伝子群市場 2021-2031

  • 市場概要
  • CRISPRおよびcas遺伝子群の製品別市場 2021-2031
  • CRISPRおよびcas遺伝子群のサービス別市場 2021-2031
  • CRISPRおよびcas遺伝子群のアプリケーション別市場 2021-2031
  • CRISPRおよびcas遺伝子群の最終用途別市場 2021-2031
  • CRISPRおよびcas遺伝子群の地域別市場 2021-2031
    • ラテンアメリカ
      • ブラジル
      • メキシコ
      • その他ラテンアメリカ地域

第13章 中東およびアフリカ CRISPRおよびcas遺伝子群市場 2021-2031

  • 市場概要
  • CRISPRおよびcas遺伝子群の製品別市場 2021-2031
  • CRISPRおよびcas遺伝子群のサービス別市場 2021-2031
  • CRISPRおよびcas遺伝子群のアプリケーション別市場 2021-2031
  • CRISPRおよびcas遺伝子群の最終用途別市場 2021-2031
  • CRISPRおよびcas遺伝子群の地域別市場 2021-2031
    • 中東・アフリカ
      • GCC
      • アフリカ
      • その他中東・アフリカ地域

第14章 企業プロファイル

  • Thermo Fisher Scientific Inc.
  • Editas Medicine Inc.
  • CRISPR Therapeutics AG
  • Intellia Therapeutics Inc.
  • Caribou Biosciences Inc.
  • その他
図表

List of Tables

  • TABLE 1 Global CRISPR And Cas Genes Market By Product, 2021-2031, USD (Million)
  • TABLE 2 Global CRISPR And Cas Genes Market By Kits & Enzymes, 2021-2031, USD (Million)
  • TABLE 3 Global CRISPR And Cas Genes Market By Service, 2021-2031, USD (Million)
  • TABLE 4 Global CRISPR And Cas Genes Market By Application, 2021-2031, USD (Million)
  • TABLE 5 Global CRISPR And Cas Genes Market By Biomedical, 2021-2031, USD (Million)
  • TABLE 6 Global CRISPR And Cas Genes Market By End-use, 2021-2031, USD (Million)
  • TABLE 7 North America CRISPR And Cas Genes Market By Product, 2021-2031, USD (Million)
  • TABLE 8 North America CRISPR And Cas Genes Market By Kits & Enzymes, 2021-2031, USD (Million)
  • TABLE 9 North America CRISPR And Cas Genes Market By Service, 2021-2031, USD (Million)
  • TABLE 10 North America CRISPR And Cas Genes Market By Application, 2021-2031, USD (Million)
  • TABLE 11 North America CRISPR And Cas Genes Market By Biomedical, 2021-2031, USD (Million)
  • TABLE 12 North America CRISPR And Cas Genes Market By End-use, 2021-2031, USD (Million)
  • TABLE 13 U.S. CRISPR And Cas Genes Market By Product, 2021-2031, USD (Million)
  • TABLE 14 U.S. CRISPR And Cas Genes Market By Kits & Enzymes, 2021-2031, USD (Million)
  • TABLE 15 U.S. CRISPR And Cas Genes Market By Service, 2021-2031, USD (Million)
  • TABLE 16 U.S. CRISPR And Cas Genes Market By Application, 2021-2031, USD (Million)
  • TABLE 17 U.S. CRISPR And Cas Genes Market By Biomedical, 2021-2031, USD (Million)
  • TABLE 18 U.S. CRISPR And Cas Genes Market By End-use, 2021-2031, USD (Million)
  • TABLE 19 Canada CRISPR And Cas Genes Market By Product, 2021-2031, USD (Million)
  • TABLE 20 Canada CRISPR And Cas Genes Market By Kits & Enzymes, 2021-2031, USD (Million)
  • TABLE 21 Canada CRISPR And Cas Genes Market By Service, 2021-2031, USD (Million)
  • TABLE 22 Canada CRISPR And Cas Genes Market By Application, 2021-2031, USD (Million)
  • TABLE 23 Canada CRISPR And Cas Genes Market By Biomedical, 2021-2031, USD (Million)
  • TABLE 24 Canada CRISPR And Cas Genes Market By End-use, 2021-2031, USD (Million)
  • TABLE 25 Rest of North America CRISPR And Cas Genes Market By Product, 2021-2031, USD (Million)
  • TABLE 26 Rest of North America CRISPR And Cas Genes Market By Kits & Enzymes, 2021-2031, USD (Million)
  • TABLE 27 Rest of North America CRISPR And Cas Genes Market By Service, 2021-2031, USD (Million)
  • TABLE 28 Rest of North America CRISPR And Cas Genes Market By Application, 2021-2031, USD (Million)
  • TABLE 29 Rest of North America CRISPR And Cas Genes Market By Biomedical, 2021-2031, USD (Million)
  • TABLE 30 Rest of North America CRISPR And Cas Genes Market By End-use, 2021-2031, USD (Million)
  • TABLE 31 UK and European Union CRISPR And Cas Genes Market By Product, 2021-2031, USD (Million)
  • TABLE 32 UK and European Union CRISPR And Cas Genes Market By Kits & Enzymes, 2021-2031, USD (Million)
  • TABLE 33 UK and European Union CRISPR And Cas Genes Market By Service, 2021-2031, USD (Million)
  • TABLE 34 UK and European Union CRISPR And Cas Genes Market By Application, 2021-2031, USD (Million)
  • TABLE 35 UK and European Union CRISPR And Cas Genes Market By Biomedical, 2021-2031, USD (Million)
  • TABLE 36 UK and European Union CRISPR And Cas Genes Market By End-use, 2021-2031, USD (Million)
  • TABLE 37 UK CRISPR And Cas Genes Market By Product, 2021-2031, USD (Million)
  • TABLE 38 UK CRISPR And Cas Genes Market By Kits & Enzymes, 2021-2031, USD (Million)
  • TABLE 39 UK CRISPR And Cas Genes Market By Service, 2021-2031, USD (Million)
  • TABLE 40 UK CRISPR And Cas Genes Market By Application, 2021-2031, USD (Million)
  • TABLE 41 UK CRISPR And Cas Genes Market By Biomedical, 2021-2031, USD (Million)
  • TABLE 42 UK CRISPR And Cas Genes Market By End-use, 2021-2031, USD (Million)
  • TABLE 43 Germany CRISPR And Cas Genes Market By Product, 2021-2031, USD (Million)
  • TABLE 44 Germany CRISPR And Cas Genes Market By Kits & Enzymes, 2021-2031, USD (Million)
  • TABLE 45 Germany CRISPR And Cas Genes Market By Service, 2021-2031, USD (Million)
  • TABLE 46 Germany CRISPR And Cas Genes Market By Application, 2021-2031, USD (Million)
  • TABLE 47 Germany CRISPR And Cas Genes Market By Biomedical, 2021-2031, USD (Million)
  • TABLE 48 Germany CRISPR And Cas Genes Market By End-use, 2021-2031, USD (Million)
  • TABLE 49 Spain CRISPR And Cas Genes Market By Product, 2021-2031, USD (Million)
  • TABLE 50 Spain CRISPR And Cas Genes Market By Kits & Enzymes, 2021-2031, USD (Million)
  • TABLE 51 Spain CRISPR And Cas Genes Market By Service, 2021-2031, USD (Million)
  • TABLE 52 Spain CRISPR And Cas Genes Market By Application, 2021-2031, USD (Million)
  • TABLE 53 Spain CRISPR And Cas Genes Market By Biomedical, 2021-2031, USD (Million)
  • TABLE 54 Spain CRISPR And Cas Genes Market By End-use, 2021-2031, USD (Million)
  • TABLE 55 Italy CRISPR And Cas Genes Market By Product, 2021-2031, USD (Million)
  • TABLE 56 Italy CRISPR And Cas Genes Market By Kits & Enzymes, 2021-2031, USD (Million)
  • TABLE 57 Italy CRISPR And Cas Genes Market By Service, 2021-2031, USD (Million)
  • TABLE 58 Italy CRISPR And Cas Genes Market By Application, 2021-2031, USD (Million)
  • TABLE 59 Italy CRISPR And Cas Genes Market By Biomedical, 2021-2031, USD (Million)
  • TABLE 60 Italy CRISPR And Cas Genes Market By End-use, 2021-2031, USD (Million)
  • TABLE 61 France CRISPR And Cas Genes Market By Product, 2021-2031, USD (Million)
  • TABLE 62 France CRISPR And Cas Genes Market By Kits & Enzymes, 2021-2031, USD (Million)
  • TABLE 63 France CRISPR And Cas Genes Market By Service, 2021-2031, USD (Million)
  • TABLE 64 France CRISPR And Cas Genes Market By Application, 2021-2031, USD (Million)
  • TABLE 65 France CRISPR And Cas Genes Market By Biomedical, 2021-2031, USD (Million)
  • TABLE 66 France CRISPR And Cas Genes Market By End-use, 2021-2031, USD (Million)
  • TABLE 67 Rest of Europe CRISPR And Cas Genes Market By Product, 2021-2031, USD (Million)
  • TABLE 68 Rest of Europe CRISPR And Cas Genes Market By Kits & Enzymes, 2021-2031, USD (Million)
  • TABLE 69 Rest of Europe CRISPR And Cas Genes Market By Service, 2021-2031, USD (Million)
  • TABLE 70 Rest of Europe CRISPR And Cas Genes Market By Application, 2021-2031, USD (Million)
  • TABLE 71 Rest of Europe CRISPR And Cas Genes Market By Biomedical, 2021-2031, USD (Million)
  • TABLE 72 Rest of Europe CRISPR And Cas Genes Market By End-use, 2021-2031, USD (Million)
  • TABLE 73 Asia CRISPR And Cas Genes Market By Product, 2021-2031, USD (Million)
  • TABLE 74 Asia CRISPR And Cas Genes Market By Kits & Enzymes, 2021-2031, USD (Million)
  • TABLE 75 Asia CRISPR And Cas Genes Market By Service, 2021-2031, USD (Million)
  • TABLE 76 Asia CRISPR And Cas Genes Market By Application, 2021-2031, USD (Million)
  • TABLE 77 Asia CRISPR And Cas Genes Market By Biomedical, 2021-2031, USD (Million)
  • TABLE 78 Asia CRISPR And Cas Genes Market By End-use, 2021-2031, USD (Million)
  • TABLE 79 China CRISPR And Cas Genes Market By Product, 2021-2031, USD (Million)
  • TABLE 80 China CRISPR And Cas Genes Market By Kits & Enzymes, 2021-2031, USD (Million)
  • TABLE 81 China CRISPR And Cas Genes Market By Service, 2021-2031, USD (Million)
  • TABLE 82 China CRISPR And Cas Genes Market By Application, 2021-2031, USD (Million)
  • TABLE 83 China CRISPR And Cas Genes Market By Biomedical, 2021-2031, USD (Million)
  • TABLE 84 China CRISPR And Cas Genes Market By End-use, 2021-2031, USD (Million)
  • TABLE 85 Japan CRISPR And Cas Genes Market By Product, 2021-2031, USD (Million)
  • TABLE 86 Japan CRISPR And Cas Genes Market By Kits & Enzymes, 2021-2031, USD (Million)
  • TABLE 87 Japan CRISPR And Cas Genes Market By Service, 2021-2031, USD (Million)
  • TABLE 88 Japan CRISPR And Cas Genes Market By Application, 2021-2031, USD (Million)
  • TABLE 89 Japan CRISPR And Cas Genes Market By Biomedical, 2021-2031, USD (Million)
  • TABLE 90 Japan CRISPR And Cas Genes Market By End-use, 2021-2031, USD (Million)
  • TABLE 91 India CRISPR And Cas Genes Market By Product, 2021-2031, USD (Million)
  • TABLE 92 India CRISPR And Cas Genes Market By Kits & Enzymes, 2021-2031, USD (Million)
  • TABLE 93 India CRISPR And Cas Genes Market By Service, 2021-2031, USD (Million)
  • TABLE 94 India CRISPR And Cas Genes Market By Application, 2021-2031, USD (Million)
  • TABLE 95 India CRISPR And Cas Genes Market By Biomedical, 2021-2031, USD (Million)
  • TABLE 96 India CRISPR And Cas Genes Market By End-use, 2021-2031, USD (Million)
  • TABLE 97 Australia CRISPR And Cas Genes Market By Product, 2021-2031, USD (Million)
  • TABLE 98 Australia CRISPR And Cas Genes Market By Kits & Enzymes, 2021-2031, USD (Million)
  • TABLE 99 Australia CRISPR And Cas Genes Market By Service, 2021-2031, USD (Million)
  • TABLE 100 Australia CRISPR And Cas Genes Market By Application, 2021-2031, USD (Million)
  • TABLE 101 Australia CRISPR And Cas Genes Market By Biomedical, 2021-2031, USD (Million)
  • TABLE 102 Australia CRISPR And Cas Genes Market By End-use, 2021-2031, USD (Million)
  • TABLE 103 South Korea CRISPR And Cas Genes Market By Product, 2021-2031, USD (Million)
  • TABLE 104 South Korea CRISPR And Cas Genes Market By Kits & Enzymes, 2021-2031, USD (Million)
  • TABLE 105 South Korea CRISPR And Cas Genes Market By Service, 2021-2031, USD (Million)
  • TABLE 106 South Korea CRISPR And Cas Genes Market By Application, 2021-2031, USD (Million)
  • TABLE 107 South Korea CRISPR And Cas Genes Market By Biomedical, 2021-2031, USD (Million)
  • TABLE 108 South Korea CRISPR And Cas Genes Market By End-use, 2021-2031, USD (Million)
  • TABLE 109 Latin America CRISPR And Cas Genes Market By Product, 2021-2031, USD (Million)
  • TABLE 110 Latin America CRISPR And Cas Genes Market By Kits & Enzymes, 2021-2031, USD (Million)
  • TABLE 111 Latin America CRISPR And Cas Genes Market By Service, 2021-2031, USD (Million)
  • TABLE 112 Latin America CRISPR And Cas Genes Market By Application, 2021-2031, USD (Million)
  • TABLE 113 Latin America CRISPR And Cas Genes Market By Biomedical, 2021-2031, USD (Million)
  • TABLE 114 Latin America CRISPR And Cas Genes Market By End-use, 2021-2031, USD (Million)
  • TABLE 115 Brazil CRISPR And Cas Genes Market By Product, 2021-2031, USD (Million)
  • TABLE 116 Brazil CRISPR And Cas Genes Market By Kits & Enzymes, 2021-2031, USD (Million)
  • TABLE 117 Brazil CRISPR And Cas Genes Market By Service, 2021-2031, USD (Million)
  • TABLE 118 Brazil CRISPR And Cas Genes Market By Application, 2021-2031, USD (Million)
  • TABLE 119 Brazil CRISPR And Cas Genes Market By Biomedical, 2021-2031, USD (Million)
  • TABLE 120 Brazil CRISPR And Cas Genes Market By End-use, 2021-2031, USD (Million)
  • TABLE 121 Mexico CRISPR And Cas Genes Market By Product, 2021-2031, USD (Million)
  • TABLE 122 Mexico CRISPR And Cas Genes Market By Kits & Enzymes, 2021-2031, USD (Million)
  • TABLE 123 Mexico CRISPR And Cas Genes Market By Service, 2021-2031, USD (Million)
  • TABLE 124 Mexico CRISPR And Cas Genes Market By Application, 2021-2031, USD (Million)
  • TABLE 125 Mexico CRISPR And Cas Genes Market By Biomedical, 2021-2031, USD (Million)
  • TABLE 126 Mexico CRISPR And Cas Genes Market By End-use, 2021-2031, USD (Million)
  • TABLE 127 Rest of Latin America CRISPR And Cas Genes Market By Product, 2021-2031, USD (Million)
  • TABLE 128 Rest of Latin America CRISPR And Cas Genes Market By Kits & Enzymes, 2021-2031, USD (Million)
  • TABLE 129 Rest of Latin America CRISPR And Cas Genes Market By Service, 2021-2031, USD (Million)
  • TABLE 130 Rest of Latin America CRISPR And Cas Genes Market By Application, 2021-2031, USD (Million)
  • TABLE 131 Rest of Latin America CRISPR And Cas Genes Market By Biomedical, 2021-2031, USD (Million)
  • TABLE 132 Rest of Latin America CRISPR And Cas Genes Market By End-use, 2021-2031, USD (Million)
  • TABLE 133 Middle East and Africa CRISPR And Cas Genes Market By Product, 2021-2031, USD (Million)
  • TABLE 134 Middle East and Africa CRISPR And Cas Genes Market By Kits & Enzymes, 2021-2031, USD (Million)
  • TABLE 135 Middle East and Africa CRISPR And Cas Genes Market By Service, 2021-2031, USD (Million)
  • TABLE 136 Middle East and Africa CRISPR And Cas Genes Market By Application, 2021-2031, USD (Million)
  • TABLE 137 Middle East and Africa CRISPR And Cas Genes Market By Biomedical, 2021-2031, USD (Million)
  • TABLE 138 Middle East and Africa CRISPR And Cas Genes Market By End-use, 2021-2031, USD (Million)
  • TABLE 139 GCC CRISPR And Cas Genes Market By Product, 2021-2031, USD (Million)
  • TABLE 140 GCC CRISPR And Cas Genes Market By Kits & Enzymes, 2021-2031, USD (Million)
  • TABLE 141 GCC CRISPR And Cas Genes Market By Service, 2021-2031, USD (Million)
  • TABLE 142 GCC CRISPR And Cas Genes Market By Application, 2021-2031, USD (Million)
  • TABLE 143 GCC CRISPR And Cas Genes Market By Biomedical, 2021-2031, USD (Million)
  • TABLE 144 GCC CRISPR And Cas Genes Market By End-use, 2021-2031, USD (Million)
  • TABLE 145 Africa CRISPR And Cas Genes Market By Product, 2021-2031, USD (Million)
  • TABLE 146 Africa CRISPR And Cas Genes Market By Kits & Enzymes, 2021-2031, USD (Million)
  • TABLE 147 Africa CRISPR And Cas Genes Market By Service, 2021-2031, USD (Million)
  • TABLE 148 Africa CRISPR And Cas Genes Market By Application, 2021-2031, USD (Million)
  • TABLE 149 Africa CRISPR And Cas Genes Market By Biomedical, 2021-2031, USD (Million)
  • TABLE 150 Africa CRISPR And Cas Genes Market By End-use, 2021-2031, USD (Million)
  • TABLE 151 Rest of Middle East and Africa CRISPR And Cas Genes Market By Product, 2021-2031, USD (Million)
  • TABLE 152 Rest of Middle East and Africa CRISPR And Cas Genes Market By Kits & Enzymes, 2021-2031, USD (Million)
  • TABLE 153 Rest of Middle East and Africa CRISPR And Cas Genes Market By Service, 2021-2031, USD (Million)
  • TABLE 154 Rest of Middle East and Africa CRISPR And Cas Genes Market By Application, 2021-2031, USD (Million)
  • TABLE 155 Rest of Middle East and Africa CRISPR And Cas Genes Market By Biomedical, 2021-2031, USD (Million)
  • TABLE 156 Rest of Middle East and Africa CRISPR And Cas Genes Market By End-use, 2021-2031, USD (Million)

List of Figures

  • FIG. 1 Global CRISPR And Cas Genes Market: Market Coverage
  • FIG. 2 Research Methodology and Data Sources
  • FIG. 3 Market Size Estimation - Top Down & Bottom-Up Approach
  • FIG. 4 Global CRISPR And Cas Genes Market: Quality Assurance
  • FIG. 5 Global CRISPR And Cas Genes Market, By Product, 2022
  • FIG. 6 Global CRISPR And Cas Genes Market, By Service, 2022
  • FIG. 7 Global CRISPR And Cas Genes Market, By Application, 2022
  • FIG. 8 Global CRISPR And Cas Genes Market, By End-use, 2022
  • FIG. 9 Global CRISPR And Cas Genes Market, By Geography, 2022
  • FIG. 10 Market Geographical Opportunity Matrix - Global CRISPR And Cas Genes Market, 2022
  • FIG. 11 Market Positioning of Key CRISPR And Cas Genes Market Players, 2022
  • FIG. 12 Global CRISPR And Cas Genes Market - Tier Analysis - Percentage of Revenues by Tier Level, 2022 Versus 2031
  • FIG. 13 Global CRISPR And Cas Genes Market, By Product, 2022 Vs 2031, %
  • FIG. 14 Global CRISPR And Cas Genes Market, By Service, 2022 Vs 2031, %
  • FIG. 15 Global CRISPR And Cas Genes Market, By Application, 2022 Vs 2031, %
  • FIG. 16 Global CRISPR And Cas Genes Market, By End-use, 2022 Vs 2031, %
  • FIG. 17 U.S. CRISPR And Cas Genes Market (US$ Million), 2021 - 2031
  • FIG. 18 Canada CRISPR And Cas Genes Market (US$ Million), 2021 - 2031
  • FIG. 19 Rest of North America CRISPR And Cas Genes Market (US$ Million), 2021 - 2031
  • FIG. 20 UK CRISPR And Cas Genes Market (US$ Million), 2021 - 2031
  • FIG. 21 Germany CRISPR And Cas Genes Market (US$ Million), 2021 - 2031
  • FIG. 22 Spain CRISPR And Cas Genes Market (US$ Million), 2021 - 2031
  • FIG. 23 Italy CRISPR And Cas Genes Market (US$ Million), 2021 - 2031
  • FIG. 24 France CRISPR And Cas Genes Market (US$ Million), 2021 - 2031
  • FIG. 25 Rest of Europe CRISPR And Cas Genes Market (US$ Million), 2021 - 2031
  • FIG. 26 China CRISPR And Cas Genes Market (US$ Million), 2021 - 2031
  • FIG. 27 Japan CRISPR And Cas Genes Market (US$ Million), 2021 - 2031
  • FIG. 28 India CRISPR And Cas Genes Market (US$ Million), 2021 - 2031
  • FIG. 29 Australia CRISPR And Cas Genes Market (US$ Million), 2021 - 2031
  • FIG. 30 South Korea CRISPR And Cas Genes Market (US$ Million), 2021 - 2031
  • FIG. 31 Rest of Asia CRISPR And Cas Genes Market (US$ Million), 2021 - 2031
  • FIG. 32 Brazil CRISPR And Cas Genes Market (US$ Million), 2021 - 2031
  • FIG. 33 Mexico CRISPR And Cas Genes Market (US$ Million), 2021 - 2031
  • FIG. 34 Rest of Latin America CRISPR And Cas Genes Market (US$ Million), 2021 - 2031
  • FIG. 35 GCC CRISPR And Cas Genes Market (US$ Million), 2021 - 2031
  • FIG. 36 Africa CRISPR And Cas Genes Market (US$ Million), 2021 - 2031
  • FIG. 37 Rest of Middle East and Africa CRISPR And Cas Genes Market (US$ Million), 2021 - 2031
目次
Product Code: 139592-05-23

CRISPR and Cas genes have become one of the most promising tools in the field of genetic engineering, revolutionizing the way we approach gene editing and genetic manipulation. The CRISPR/Cas system is a naturally occurring mechanism in bacteria that allows them to defend themselves against invading viruses. This system can be adapted to target and modify specific genes, making it a powerful tool in research and medicine. The global CRISPR and Cas genes market is expected to grow significantly in the coming years, with a CAGR of 18.5% during the forecast period of 2023 to 2031. This growth is driven by the increasing demand for gene editing technologies in various applications such as agriculture, pharmaceuticals, and biotechnology. The pharmaceutical and biotechnology industries are the major contributors to the growth of the CRISPR and Cas genes market. The technology is being used in drug discovery and development, with the potential to treat a wide range of genetic disorders. The agriculture industry is also adopting this technology to improve crop yields and develop disease-resistant crops.

Increasing Demand for Gene Editing Technologies in Pharmaceutical Industry

The pharmaceutical industry is a major driver of the CRISPR and Cas genes market. The technology is being used in drug discovery and development, with the potential to treat a wide range of genetic disorders. The global gene editing market is expected to reach $9.5 billion by 2025, with the CRISPR/Cas system being the most widely used gene editing technology. Several companies are investing heavily in the development of CRISPR-based therapies, including CRISPR Therapeutics AG, Intellia Therapeutics, and Editas Medicine, among others.

Adoption of CRISPR/Cas Technology in Agriculture

The agriculture industry is also driving the growth of the CRISPR and Cas genes market. The technology is being used to improve crop yields and develop disease-resistant crops. The global agricultural biotechnology market is expected to cross $55 billion by 2025, with the CRISPR/Cas system being one of the key technologies driving this growth. Companies such as Bayer AG, DuPont Pioneer, and DowDuPont are investing heavily in the development of CRISPR-edited crops.

Rising Prevalence of Genetic Disorders

The rising prevalence of genetic disorders is driving the demand for gene editing technologies such as CRISPR and Cas genes. According to the World Health Organization, genetic disorders affect millions of people worldwide, with an estimated 1 in 20 live births being affected by a genetic disorder. The CRISPR/Cas system has the potential to treat a wide range of genetic disorders, including sickle cell anemia, cystic fibrosis, and Huntington's disease, among others. Several clinical trials are underway to test the safety and efficacy of CRISPR-based therapies for genetic disorders, which could further drive the growth of the CRISPR and Cas genes market.

Off-Target Effects and Ethical Concerns

One of the major restraints of the CRISPR and Cas genes market is the potential for off-target effects, which can result in unintended and potentially harmful changes to the genome. While the CRISPR/Cas system is highly precise, it is not perfect, and there is still a risk of off-target effects. This has led to concerns about the safety and ethical implications of using this technology for gene editing. In addition, there are also concerns about the potential misuse of this technology for non-medical purposes, such as enhancing human traits. These concerns could lead to increased regulatory scrutiny and slower adoption of the technology, which could restrain the growth of the CRISPR and Cas genes market.

Biomedical Segment to Dominate the Market Revenues

The CRISPR and Cas genes market is expected to witness significant growth in both the biomedical and agriculture segments. In terms of revenue, the biomedical segment is expected to dominate the market due to the high demand for gene editing technologies in drug discovery and development. The biomedical segment accounted for the largest share of the CRISPR and Cas genes market in 2022, the segment is also expected to dominate the market during the forecast period of 2023 to 2031. On the other hand, the agriculture segment is expected to witness the highest CAGR during the forecast period, driven by the increasing demand for disease-resistant and high-yielding crops. The CRISPR/Cas system is being used to develop crops with desirable traits, such as increased yield, drought resistance, and disease resistance. Several companies, including Bayer AG and DowDuPont, are investing heavily in the development of CRISPR-edited crops, which could further drive the growth of the agriculture segment.

Biotechnology and Pharmaceutical Companies to Dominate the Market Revenues

The CRISPR and Cas genes market is also segmented by end-use, including biotechnology and pharmaceutical companies, academics and government research institutes, and contract research organizations (CROs). Biotechnology and pharmaceutical companies are expected to dominate the market in terms of revenue, owing to the high demand for gene editing technologies in drug discovery and development. The biotechnology and pharmaceutical companies segment accounted for the largest share of the CRISPR and Cas genes market in 2022. However, the highest CAGR during the forecast period of 2023 to 2031 is expected in the contract research organizations (CROs) segment, driven by the increasing outsourcing of preclinical and clinical research activities by biotechnology and pharmaceutical companies. CROs provide a wide range of services, including drug discovery and development, clinical trials, and regulatory services, among others. The use of CRISPR and Cas genes in preclinical and clinical research activities is expected to increase, which could further drive the growth of the CROs segment.

North America Remains as the Global Leader

North America accounted for the largest share of the market in 2022, owing to the presence of several key players in the region and the high adoption rate of gene editing technologies in the biotechnology and pharmaceutical industries. However, the highest CAGR is expected in the Asia-Pacific region, driven by the increasing investments in biotechnology research and the growing prevalence of genetic disorders in the region. The region is also home to several emerging biotechnology and pharmaceutical companies, which could further drive the growth of the market. Europe is also expected to contribute significantly to the growth of the CRISPR and Cas genes market, owing to the increasing government funding for genome editing research and the growing demand for genetically modified crops in the region.

Market Competition to Intensify during the Forecast Period

The CRISPR and Cas genes market is highly competitive, with several key players operating in the market. Some of the top players in the market include Thermo Fisher Scientific, Inc., Editas Medicine, Inc., CRISPR Therapeutics AG, Intellia Therapeutics, Inc., and Caribou Biosciences, Inc., among others. These players are focusing on strategic collaborations, partnerships, and mergers and acquisitions to expand their market presence and strengthen their product portfolios. For instance, in 2020, Thermo Fisher Scientific acquired QIAGEN N.V., a leading provider of molecular diagnostics and sample preparation technologies, to expand its life sciences offerings. In addition, Editas Medicine has entered into several collaborations with key players in the biotechnology and pharmaceutical industries to advance its CRISPR gene editing technology. Furthermore, several key players are investing in research and development activities to develop new and innovative gene editing technologies. For instance, CRISPR Therapeutics is developing a portfolio of CRISPR-based therapies for a wide range of genetic disorders, while Intellia Therapeutics is developing a proprietary platform for the in vivo delivery of CRISPR-Cas9 gene editing technology. Moreover, companies are also focusing on obtaining regulatory approvals for their gene editing technologies. For instance, in 2019, CRISPR Therapeutics and Vertex Pharmaceuticals received FDA approval for their gene therapy, which uses CRISPR-Cas9 technology to treat sickle cell disease.

Historical & Forecast Period

This study report represents analysis of each segment from 2021 to 2031 considering 2022 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2022 to 2031.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of CRISPR And Cas Genes market are as follows:

  • Research and development budgets of manufacturers and government spending
  • Revenues of key companies in the market segment
  • Number of end users and consumption volume, price and value.

Geographical revenues generate by countries considered in the report:

Micro and macro environment factors that are currently influencing the CRISPR And Cas Genes market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Market Segmentation

Product

  • Kits & Enzymes
    • Vector-based Cas
    • DNA-free Cas
  • Libraries
  • Design Tool
  • Antibodies
  • Others

Service

  • Cell Line Engineering
  • gRNA Design
  • Microbial Gene Editing
  • DNA Synthesis

Application

  • Biomedical
    • Genome Engineering
    • Disease Model Studies
    • Functional Genomics
    • Epigenetics
    • Others
  • Agricultural

End-use

  • Biotechnology & Pharmaceutical Companies
  • Academics & Government Research Institutes
  • Contract Research Organizations (CROs)

Region Segment (2021-2031; US$ Million)

  • North America
    • U.S.
    • Canada
    • Rest of North America
  • UK and European Union
    • UK
    • Germany
    • Spain
    • Italy
    • France
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East and Africa
    • GCC
    • Africa
    • Rest of Middle East and Africa

Key questions answered in this report:

  • What are the key micro and macro environmental factors that are impacting the growth of CRISPR And Cas Genes market?
  • What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
  • Estimated forecast and market projections up to 2031.
  • Which segment accounts for the fastest CAGR during the forecast period?
  • Which market segment holds a larger market share and why?
  • Are low and middle-income economies investing in the CRISPR And Cas Genes market?
  • Which is the largest regional market for CRISPR And Cas Genes market?
  • What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
  • Which are the key trends driving CRISPR And Cas Genes market growth?
  • Who are the key competitors and what are their key strategies to enhance their market presence in the CRISPR And Cas Genes market worldwide?

Table of Contents

1. Preface

  • 1.1. Report Description
    • 1.1.1. Purpose of the Report
    • 1.1.2. Target Audience
    • 1.1.3. Key Offerings
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
    • 1.3.1. Phase I - Secondary Research
    • 1.3.2. Phase II - Primary Research
    • 1.3.3. Phase III - Expert Panel Review
    • 1.3.4. Assumptions
    • 1.3.5. Approach Adopted

2. Executive Summary

  • 2.1. Market Snapshot: Global CRISPR And Cas Genes Market
  • 2.2. Global CRISPR And Cas Genes Market, By Product, 2022 (US$ Million)
  • 2.3. Global CRISPR And Cas Genes Market, By Service, 2022 (US$ Million)
  • 2.4. Global CRISPR And Cas Genes Market, By Application, 2022 (US$ Million)
  • 2.5. Global CRISPR And Cas Genes Market, By End-use, 2022 (US$ Million)
  • 2.6. Global CRISPR And Cas Genes Market, By Geography, 2022 (US$ Million)
  • 2.7. Attractive Investment Proposition by Geography, 2022

3. CRISPR And Cas Genes Market: Competitive Analysis

  • 3.1. Market Positioning of Key CRISPR And Cas Genes Market Vendors
  • 3.2. Strategies Adopted by CRISPR And Cas Genes Market Vendors
  • 3.3. Key Industry Strategies
  • 3.4. Tier Analysis 2022 Versus 2031

4. CRISPR And Cas Genes Market: Macro Analysis & Market Dynamics

  • 4.1. Introduction
  • 4.2. Global CRISPR And Cas Genes Market Value, 2021 - 2031, (US$ Million)
  • 4.3. Market Dynamics
    • 4.3.1. Market Drivers
    • 4.3.2. Market Restraints
    • 4.3.3. Key Challenges
    • 4.3.4. Key Opportunities
  • 4.4. Impact Analysis of Drivers and Restraints
  • 4.5. See-Saw Analysis

5. CRISPR And Cas Genes Market: By Product, 2021-2031, USD (Million)

  • 5.1. Market Overview
  • 5.2. Growth & Revenue Analysis: 2022 Versus 2031
  • 5.3. Market Segmentation
    • 5.3.1. Kits & Enzymes
      • 5.3.1.1. Vector-based Cas
      • 5.3.1.2. DNA-free Cas
    • 5.3.2. Libraries
    • 5.3.3. Design Tool
    • 5.3.4. Antibodies
    • 5.3.5. Others

6. CRISPR And Cas Genes Market: By Service, 2021-2031, USD (Million)

  • 6.1. Market Overview
  • 6.2. Growth & Revenue Analysis: 2022 Versus 2031
  • 6.3. Market Segmentation
    • 6.3.1. Cell Line Engineering
    • 6.3.2. gRNA Design
    • 6.3.3. Microbial Gene Editing
    • 6.3.4. DNA Synthesis

7. CRISPR And Cas Genes Market: By Application, 2021-2031, USD (Million)

  • 7.1. Market Overview
  • 7.2. Growth & Revenue Analysis: 2022 Versus 2031
  • 7.3. Market Segmentation
    • 7.3.1. Biomedical
      • 7.3.1.1. Genome Engineering
      • 7.3.1.2. Disease Model Studies
      • 7.3.1.3. Functional Genomics
      • 7.3.1.4. Epigenetics
      • 7.3.1.5. Others
    • 7.3.2. Agricultural

8. CRISPR And Cas Genes Market: By End-use, 2021-2031, USD (Million)

  • 8.1. Market Overview
  • 8.2. Growth & Revenue Analysis: 2022 Versus 2031
  • 8.3. Market Segmentation
    • 8.3.1. Biotechnology & Pharmaceutical Companies
    • 8.3.2. Academics & Government Research Institutes
    • 8.3.3. Contract Research Organizations (CROs)

9. North America CRISPR And Cas Genes Market, 2021-2031, USD (Million)

  • 9.1. Market Overview
  • 9.2. CRISPR And Cas Genes Market: By Product, 2021-2031, USD (Million)
  • 9.3. CRISPR And Cas Genes Market: By Service, 2021-2031, USD (Million)
  • 9.4. CRISPR And Cas Genes Market: By Application, 2021-2031, USD (Million)
  • 9.5. CRISPR And Cas Genes Market: By End-use, 2021-2031, USD (Million)
  • 9.6.CRISPR And Cas Genes Market: By Region, 2021-2031, USD (Million)
    • 9.6.1.North America
      • 9.6.1.1. U.S.
        • 9.6.1.1.1. CRISPR And Cas Genes Market: By Product, 2021-2031, USD (Million)
        • 9.6.1.1.1. CRISPR And Cas Genes Market: By Service, 2021-2031, USD (Million)
        • 9.6.1.1.1. CRISPR And Cas Genes Market: By Application, 2021-2031, USD (Million)
        • 9.6.1.1.1. CRISPR And Cas Genes Market: By End-use, 2021-2031, USD (Million)
      • 9.6.1.2. Canada
        • 9.6.1.2.1. CRISPR And Cas Genes Market: By Product, 2021-2031, USD (Million)
        • 9.6.1.2.1. CRISPR And Cas Genes Market: By Service, 2021-2031, USD (Million)
        • 9.6.1.2.1. CRISPR And Cas Genes Market: By Application, 2021-2031, USD (Million)
        • 9.6.1.2.1. CRISPR And Cas Genes Market: By End-use, 2021-2031, USD (Million)
      • 9.6.1.3. Rest of North America
        • 9.6.1.3.1. CRISPR And Cas Genes Market: By Product, 2021-2031, USD (Million)
        • 9.6.1.3.1. CRISPR And Cas Genes Market: By Service, 2021-2031, USD (Million)
        • 9.6.1.3.1. CRISPR And Cas Genes Market: By Application, 2021-2031, USD (Million)
        • 9.6.1.3.1. CRISPR And Cas Genes Market: By End-use, 2021-2031, USD (Million)

10. UK and European Union CRISPR And Cas Genes Market, 2021-2031, USD (Million)

  • 10.1. Market Overview
  • 10.2. CRISPR And Cas Genes Market: By Product, 2021-2031, USD (Million)
  • 10.3. CRISPR And Cas Genes Market: By Service, 2021-2031, USD (Million)
  • 10.4. CRISPR And Cas Genes Market: By Application, 2021-2031, USD (Million)
  • 10.5. CRISPR And Cas Genes Market: By End-use, 2021-2031, USD (Million)
  • 10.6.CRISPR And Cas Genes Market: By Region, 2021-2031, USD (Million)
    • 10.6.1.UK and European Union
      • 10.6.1.1. UK
        • 10.6.1.1.1. CRISPR And Cas Genes Market: By Product, 2021-2031, USD (Million)
        • 10.6.1.1.1. CRISPR And Cas Genes Market: By Service, 2021-2031, USD (Million)
        • 10.6.1.1.1. CRISPR And Cas Genes Market: By Application, 2021-2031, USD (Million)
        • 10.6.1.1.1. CRISPR And Cas Genes Market: By End-use, 2021-2031, USD (Million)
      • 10.6.1.2. Germany
        • 10.6.1.2.1. CRISPR And Cas Genes Market: By Product, 2021-2031, USD (Million)
        • 10.6.1.2.1. CRISPR And Cas Genes Market: By Service, 2021-2031, USD (Million)
        • 10.6.1.2.1. CRISPR And Cas Genes Market: By Application, 2021-2031, USD (Million)
        • 10.6.1.2.1. CRISPR And Cas Genes Market: By End-use, 2021-2031, USD (Million)
      • 10.6.1.3. Spain
        • 10.6.1.3.1. CRISPR And Cas Genes Market: By Product, 2021-2031, USD (Million)
        • 10.6.1.3.1. CRISPR And Cas Genes Market: By Service, 2021-2031, USD (Million)
        • 10.6.1.3.1. CRISPR And Cas Genes Market: By Application, 2021-2031, USD (Million)
        • 10.6.1.3.1. CRISPR And Cas Genes Market: By End-use, 2021-2031, USD (Million)
      • 10.6.1.4. Italy
        • 10.6.1.4.1. CRISPR And Cas Genes Market: By Product, 2021-2031, USD (Million)
        • 10.6.1.4.1. CRISPR And Cas Genes Market: By Service, 2021-2031, USD (Million)
        • 10.6.1.4.1. CRISPR And Cas Genes Market: By Application, 2021-2031, USD (Million)
        • 10.6.1.4.1. CRISPR And Cas Genes Market: By End-use, 2021-2031, USD (Million)
      • 10.6.1.5. France
        • 10.6.1.5.1. CRISPR And Cas Genes Market: By Product, 2021-2031, USD (Million)
        • 10.6.1.5.1. CRISPR And Cas Genes Market: By Service, 2021-2031, USD (Million)
        • 10.6.1.5.1. CRISPR And Cas Genes Market: By Application, 2021-2031, USD (Million)
        • 10.6.1.5.1. CRISPR And Cas Genes Market: By End-use, 2021-2031, USD (Million)
      • 10.6.1.6. Rest of Europe
        • 10.6.1.6.1. CRISPR And Cas Genes Market: By Product, 2021-2031, USD (Million)
        • 10.6.1.6.1. CRISPR And Cas Genes Market: By Service, 2021-2031, USD (Million)
        • 10.6.1.6.1. CRISPR And Cas Genes Market: By Application, 2021-2031, USD (Million)
        • 10.6.1.6.1. CRISPR And Cas Genes Market: By End-use, 2021-2031, USD (Million)

11. Asia Pacific CRISPR And Cas Genes Market, 2021-2031, USD (Million)

  • 11.1. Market Overview
  • 11.2. CRISPR And Cas Genes Market: By Product, 2021-2031, USD (Million)
  • 11.3. CRISPR And Cas Genes Market: By Service, 2021-2031, USD (Million)
  • 11.4. CRISPR And Cas Genes Market: By Application, 2021-2031, USD (Million)
  • 11.5. CRISPR And Cas Genes Market: By End-use, 2021-2031, USD (Million)
  • 11.6.CRISPR And Cas Genes Market: By Region, 2021-2031, USD (Million)
    • 11.6.1.Asia Pacific
      • 11.6.1.1. China
        • 11.6.1.1.1. CRISPR And Cas Genes Market: By Product, 2021-2031, USD (Million)
        • 11.6.1.1.1. CRISPR And Cas Genes Market: By Service, 2021-2031, USD (Million)
        • 11.6.1.1.1. CRISPR And Cas Genes Market: By Application, 2021-2031, USD (Million)
        • 11.6.1.1.1. CRISPR And Cas Genes Market: By End-use, 2021-2031, USD (Million)
      • 11.6.1.2. Japan
        • 11.6.1.2.1. CRISPR And Cas Genes Market: By Product, 2021-2031, USD (Million)
        • 11.6.1.2.1. CRISPR And Cas Genes Market: By Service, 2021-2031, USD (Million)
        • 11.6.1.2.1. CRISPR And Cas Genes Market: By Application, 2021-2031, USD (Million)
        • 11.6.1.2.1. CRISPR And Cas Genes Market: By End-use, 2021-2031, USD (Million)
      • 11.6.1.3. India
        • 11.6.1.3.1. CRISPR And Cas Genes Market: By Product, 2021-2031, USD (Million)
        • 11.6.1.3.1. CRISPR And Cas Genes Market: By Service, 2021-2031, USD (Million)
        • 11.6.1.3.1. CRISPR And Cas Genes Market: By Application, 2021-2031, USD (Million)
        • 11.6.1.3.1. CRISPR And Cas Genes Market: By End-use, 2021-2031, USD (Million)
      • 11.6.1.4. Australia
        • 11.6.1.4.1. CRISPR And Cas Genes Market: By Product, 2021-2031, USD (Million)
        • 11.6.1.4.1. CRISPR And Cas Genes Market: By Service, 2021-2031, USD (Million)
        • 11.6.1.4.1. CRISPR And Cas Genes Market: By Application, 2021-2031, USD (Million)
        • 11.6.1.4.1. CRISPR And Cas Genes Market: By End-use, 2021-2031, USD (Million)
      • 11.6.1.5. South Korea
        • 11.6.1.5.1. CRISPR And Cas Genes Market: By Product, 2021-2031, USD (Million)
        • 11.6.1.5.1. CRISPR And Cas Genes Market: By Service, 2021-2031, USD (Million)
        • 11.6.1.5.1. CRISPR And Cas Genes Market: By Application, 2021-2031, USD (Million)
        • 11.6.1.5.1. CRISPR And Cas Genes Market: By End-use, 2021-2031, USD (Million)
      • 11.6.1.6. Rest of Asia Pacific
        • 11.6.1.6.1. CRISPR And Cas Genes Market: By Product, 2021-2031, USD (Million)
        • 11.6.1.6.1. CRISPR And Cas Genes Market: By Service, 2021-2031, USD (Million)
        • 11.6.1.6.1. CRISPR And Cas Genes Market: By Application, 2021-2031, USD (Million)
        • 11.6.1.6.1. CRISPR And Cas Genes Market: By End-use, 2021-2031, USD (Million)

12. Latin America CRISPR And Cas Genes Market, 2021-2031, USD (Million)

  • 12.1. Market Overview
  • 12.2. CRISPR And Cas Genes Market: By Product, 2021-2031, USD (Million)
  • 12.3. CRISPR And Cas Genes Market: By Service, 2021-2031, USD (Million)
  • 12.4. CRISPR And Cas Genes Market: By Application, 2021-2031, USD (Million)
  • 12.5. CRISPR And Cas Genes Market: By End-use, 2021-2031, USD (Million)
  • 12.6.CRISPR And Cas Genes Market: By Region, 2021-2031, USD (Million)
    • 12.6.1.Latin America
      • 12.6.1.1. Brazil
        • 12.6.1.1.1. CRISPR And Cas Genes Market: By Product, 2021-2031, USD (Million)
        • 12.6.1.1.1. CRISPR And Cas Genes Market: By Service, 2021-2031, USD (Million)
        • 12.6.1.1.1. CRISPR And Cas Genes Market: By Application, 2021-2031, USD (Million)
        • 12.6.1.1.1. CRISPR And Cas Genes Market: By End-use, 2021-2031, USD (Million)
      • 12.6.1.2. Mexico
        • 12.6.1.2.1. CRISPR And Cas Genes Market: By Product, 2021-2031, USD (Million)
        • 12.6.1.2.1. CRISPR And Cas Genes Market: By Service, 2021-2031, USD (Million)
        • 12.6.1.2.1. CRISPR And Cas Genes Market: By Application, 2021-2031, USD (Million)
        • 12.6.1.2.1. CRISPR And Cas Genes Market: By End-use, 2021-2031, USD (Million)
      • 12.6.1.3. Rest of Latin America
        • 12.6.1.3.1. CRISPR And Cas Genes Market: By Product, 2021-2031, USD (Million)
        • 12.6.1.3.1. CRISPR And Cas Genes Market: By Service, 2021-2031, USD (Million)
        • 12.6.1.3.1. CRISPR And Cas Genes Market: By Application, 2021-2031, USD (Million)
        • 12.6.1.3.1. CRISPR And Cas Genes Market: By End-use, 2021-2031, USD (Million)

13. Middle East and Africa CRISPR And Cas Genes Market, 2021-2031, USD (Million)

  • 13.1. Market Overview
  • 13.2. CRISPR And Cas Genes Market: By Product, 2021-2031, USD (Million)
  • 13.3. CRISPR And Cas Genes Market: By Service, 2021-2031, USD (Million)
  • 13.4. CRISPR And Cas Genes Market: By Application, 2021-2031, USD (Million)
  • 13.5. CRISPR And Cas Genes Market: By End-use, 2021-2031, USD (Million)
  • 13.6.CRISPR And Cas Genes Market: By Region, 2021-2031, USD (Million)
    • 13.6.1.Middle East and Africa
      • 13.6.1.1. GCC
        • 13.6.1.1.1. CRISPR And Cas Genes Market: By Product, 2021-2031, USD (Million)
        • 13.6.1.1.1. CRISPR And Cas Genes Market: By Service, 2021-2031, USD (Million)
        • 13.6.1.1.1. CRISPR And Cas Genes Market: By Application, 2021-2031, USD (Million)
        • 13.6.1.1.1. CRISPR And Cas Genes Market: By End-use, 2021-2031, USD (Million)
      • 13.6.1.2. Africa
        • 13.6.1.2.1. CRISPR And Cas Genes Market: By Product, 2021-2031, USD (Million)
        • 13.6.1.2.1. CRISPR And Cas Genes Market: By Service, 2021-2031, USD (Million)
        • 13.6.1.2.1. CRISPR And Cas Genes Market: By Application, 2021-2031, USD (Million)
        • 13.6.1.2.1. CRISPR And Cas Genes Market: By End-use, 2021-2031, USD (Million)
      • 13.6.1.3. Rest of Middle East and Africa
        • 13.6.1.3.1. CRISPR And Cas Genes Market: By Product, 2021-2031, USD (Million)
        • 13.6.1.3.1. CRISPR And Cas Genes Market: By Service, 2021-2031, USD (Million)
        • 13.6.1.3.1. CRISPR And Cas Genes Market: By Application, 2021-2031, USD (Million)
        • 13.6.1.3.1. CRISPR And Cas Genes Market: By End-use, 2021-2031, USD (Million)

14. Company Profile

  • 14.1. Thermo Fisher Scientific, Inc.
    • 14.1.1. Company Overview
    • 14.1.2. Financial Performance
    • 14.1.3. Product Portfolio
    • 14.1.4. Strategic Initiatives
  • 14.2. Editas Medicine, Inc.
    • 14.2.1. Company Overview
    • 14.2.2. Financial Performance
    • 14.2.3. Product Portfolio
    • 14.2.4. Strategic Initiatives
  • 14.3. CRISPR Therapeutics AG
    • 14.3.1. Company Overview
    • 14.3.2. Financial Performance
    • 14.3.3. Product Portfolio
    • 14.3.4. Strategic Initiatives
  • 14.4. Intellia Therapeutics, Inc.
    • 14.4.1. Company Overview
    • 14.4.2. Financial Performance
    • 14.4.3. Product Portfolio
    • 14.4.4. Strategic Initiatives
  • 14.5. Caribou Biosciences, Inc.
    • 14.5.1. Company Overview
    • 14.5.2. Financial Performance
    • 14.5.3. Product Portfolio
    • 14.5.4. Strategic Initiatives
  • 14.6. Other Notable Players
    • 14.6.1. Company Overview
    • 14.6.2. Financial Performance
    • 14.6.3. Product Portfolio
    • 14.6.4. Strategic Initiatives